title: Systematic identification of proteins that elicit drug side effects.
abstract: Side effect similarities of drugs have recently been employed to predict new drug targets, and networks of side effects and targets have been used to better understand the mechanism of action of drugs. Here, we report a large-scale analysis to systematically predict and characterize proteins that cause drug side effects. We integrated phenotypic data obtained during clinical trials with known drug-target relations to identify overrepresented protein-side effect combinations. Using independent data, we confirm that most of these overrepresentations point to proteins which, when perturbed, cause side effects. Of 1428 side effects studied, 732 were predicted to be predominantly caused by individual proteins, at least 137 of them backed by existing pharmacological or phenotypic data. We prove this concept in vivo by confirming our prediction that activation of the serotonin 7 receptor (HTR7) is responsible for hyperesthesia in mice, which, in turn, can be prevented by a drug that selectively inhibits HTR7. Taken together, we show that a large fraction of complex drug side effects are mediated by individual proteins and create a reference for such relations.
authors: Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
authors: Michael
authors: M
authors: Kuhn
authors: Mumna
authors: M
authors: Al Banchaabouchi
authors: Monica
authors: M
authors: Campillos
authors: Lars Juhl
authors: LJ
authors: Jensen
authors: Cornelius
authors: C
authors: Gross
authors: Anne-Claude
authors: AC
authors: Gavin
authors: Peer
authors: P
authors: Bork
mesh_terms: D000465:Algorithms; D000818:Animals; D002986:Clinical Trials as Topic; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D020869:Gene Expression Profiling; D006801:Humans; D006941:Hyperesthesia / Q000139:chemically induced / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control; D008297:Male; D051379:Mice; D023303:Oxazolidinones / Q000009:adverse effects*; D010597:Pharmacogenetics; D010636:Phenols / Q000494:pharmacology; D011237:Predictive Value of Tests; D011985:Receptors, Serotonin / Q000235:genetics / Q000378:metabolism*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000009:adverse effects*; D058829:Serotonin 5-HT1 Receptor Antagonists / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D014363:Tryptamines / Q000009:adverse effects*
chemical_list: D023303:Oxazolidinones; D010636:Phenols; D011985:Receptors, Serotonin; C404922:SB 269970; D058825:Serotonin 5-HT1 Receptor Agonists; D058829:Serotonin 5-HT1 Receptor Antagonists; D013449:Sulfonamides; D014363:Tryptamines; C104425:serotonin 7 receptor; C089750:zolmitriptan
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D876-80
references: 22075997
references: Neurosci Lett. 1989 Dec 15;107(1-3):227-32
references: 2533334
references: PLoS Comput Biol. 2009 May;5(5):e1000387
references: 19436720
references: J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):493-500
references: 12653513
references: Science. 2008 Jul 11;321(5886):263-6
references: 18621671
references: Neuroreport. 2009 Feb 18;20(3):325-30
references: 19190523
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
references: 21948594
references: Nat Rev Drug Discov. 2006 Dec;5(12):993-6
references: 17139284
references: Drug Discov Today. 2005 Nov 1;10(21):1421-33
references: 16243262
references: ChemMedChem. 2007 Jun;2(6):861-73
references: 17477341
references: PLoS Comput Biol. 2009 Jul;5(7):e1000441
references: 19629158
references: Nucleic Acids Res. 2010 Jan;38(Database issue):D586-92
references: 19864252
references: Nat Rev Drug Discov. 2006 Oct;5(10):821-34
references: 17016423
references: Behav Brain Res. 1993 Sep 30;56(2):171-6
references: 8240711
references: Nat Chem Biol. 2008 Nov;4(11):682-90
references: 18936753
references: Genome Biol. 2009;10(9):238
references: 19723347
references: PLoS Comput Biol. 2007 Nov;3(11):e217
references: 18052534
references: J Neurosci Methods. 1998 Oct 1;84(1-2):41-7
references: 9821632
references: Pharmacol Biochem Behav. 1998 Feb;59(2):477-85
references: 9476998
references: Pharmacol Biochem Behav. 2002 Apr;71(4):533-54
references: 11888546
references: Bioinformatics. 2012 Sep 15;28(18):i522-i528
references: 22962476
references: Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):129-35
references: 20803507
references: J Chem Inf Model. 2009 Feb;49(2):308-17
references: 19434832
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D919-22
references: 17942422
references: Curr Opin Drug Discov Devel. 2003 Jul;6(4):470-80
references: 12951810
references: Nature. 2012 Jun 10;486(7403):361-7
references: 22722194
references: Pain. 1999 Mar;80(1-2):67-82
references: 10204719
references: Nucleic Acids Res. 2006 Jan 1;34(Database issue):D673-7
references: 16381956
references: Mol Pain. 2010 Oct 26;6:70
references: 20977736
references: Mol Syst Biol. 2010;6:343
references: 20087340
references: Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6
references: 18048412
references: J Biomed Inform. 2010 Jun;43(3):376-84
references: 20434586
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
references: 12883005
references: Neuropharmacology. 2004 Jan;46(1):52-62
references: 14654097
references: FEBS Lett. 2008 Apr 9;582(8):1283-90
references: 18291108
references: J Med Chem. 2000 Feb 10;43(3):342-5
references: 10669560
references: Protein Sci. 1992 Mar;1(3):409-17
references: 1304348